Columnistas Expertos

Alan Moss
Columnista Experto de SIIC

Assistant Professor of Medicine. Gastroenterology., Harvard Medical School, Boston, EE.UU.

Artículos publicados (selección):

REVISAN LAS POSIBLES CONDUCTAS FRENTE A LA COLITIS ULCEROSA REFRACTARIA A ESTEROIDES
Columnista Experto de SIIC Alan Moss en colaboración con

Fecha de aprobación: 6 de octubre, 2010
Primera edición en siicsalud: 28 de febrero, 2011
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/114720
Especialidad principal: Gastroenterología
Medicina Interna

Especialidades relacionadas:

Anatomía Patológica,

Cirugía,

Diagnóstico por Imágenes,

Diagnóstico por Laboratorio,

Farmacología,

Doherty GA, Moss AC, Cheifetz AS. Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis"., Am J Gastroenterol. 105(105):2111-2., 2010

Lawlor G, Ahmed A, Moss AC. Once-daily mesalamine granules for ulcerative colitis., Expert Rev Clin Immunol. 6(6):521-6, 2010

Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?, Inflamm Bowel Dis. 16(16):1620-7, 2010

Moss AC. CMV in moderately active colitis: much ado about nothing?, Dig Dis Sci. 55(55):880-2, 2010

Cury DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease., Inflamm Bowel Dis. 16(16):1393-6, 2010

Cury DB, Moss AC, Elias G, Nakao A. Adalimumab for cutaneous metastatic Crohn's disease., Inflamm Bowel Dis. 16(16):723-4, 2010

Tukey M, Pleskow D, Legnani P, Cheifetz AS, Moss AC. The utility of capsule endoscopy in patients with suspected Crohn's disease., Am J Gastroenterol. 104(104):2734-9, 2009

Moss AC, Kim KJ, Fernandez-Becker N, Cury D, Cheifetz AS. Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab., Dig Dis Sci. 55(55):1413-20, 2010

Patil SA, Moss AC. Balsalazide disodium for the treatment of ulcerative colitis., Expert Rev Gastroenterol Hepatol. 2(2):177-84, 2008

Moss AC, Cheifetz AS. How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?, Inflamm Bowel Dis. 14(14):155-6, 2008

Kokkotou E, Moss AC, Torres D, Karagiannides I, Cheifetz A, Liu S, O'Brien M, Maratos-Flier E, Pothoulakis C. Melanin-concentrating hormone as a mediator of intestinal inflammation., Proc Natl Acad Sci U S A. 105(105):10613-8, 2008

Moss AC, Peppercorn MA. Steroid-refractory severe ulcerative colitis: what are the available treatment options?, Drugs. 68(68):1157-67, 2008

Mehta BP, Shmerling RH, Moss AC. Pseudogout after polyethylene glycol bowel cleansing., J Clin Gastroenterol. 43(43):95-6, 2009

Fernandez-Becker NQ, Moss AC. Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes., Drugs. 68(68):1089-103, 2008

Kokkotou E, Moss AC, Michos A, Espinoza D, Cloud JW, Mustafa N, O'Brien M, Pothoulakis C, Kelly CP. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters., Antimicrob Agents Chemother. 52(52):1121-6, 2008

Alan Moss

Dirección profesional:
Rose 1 / East, 330 Brooklien Ave - MA 02215, Boston, EE.UU.

ua40317

Acerca de SIIC

Acceso para suscriptores